Lyngby, Denmark

Anne Worsaae

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • Lyngby, DK (2001 - 2023)
  • Kongens Lyngby, DK (2024)

Company Filing History:


Years Active: 2001-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Journey of Anne Worsaae

Introduction

Anne Worsaae, a talented inventor based in Lyngby, Denmark, has made significant contributions to the field of immunology and cancer treatment. With a portfolio of four patents, her innovative work focuses on enhancing immune responses and addressing cancer-related challenges.

Latest Patents

Among her latest inventions, Worsaae has developed anti-NKG2A antibodies and compositions, which are designed to enhance immunity in patients and treat cancer. Another notable invention is the anti-AXL antibodies and compositions, aimed at treating diseases and conditions associated with AXL activity, such as cancer. These breakthroughs underline her commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout her career, Worsaae has been associated with prominent companies such as Novo Nordisk A/S and Les Laboratoires Servier. Her work in these organizations highlights her expertise and ability to contribute to cutting-edge research and development in biomedicine.

Collaborations

Worsaae’s journey has been enriched through collaborations with notable individuals in her field, including Randi Westh Hansen and Thomas Dyrberg. These partnerships showcase the collaborative spirit that drives innovation and the sharing of knowledge among inventors and researchers.

Conclusion

Anne Worsaae is a noteworthy figure in the realm of invention, demonstrating the impact that dedicated inventors can have on healthcare and treatment options. With her ongoing contributions, she continues to pave the way for future innovations that can enhance patient care and combat serious diseases like cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…